CD8A and granular corneal dystrophy type II: We therefore analyzed previously published scRNA seq data of CD8+ T-IEL from healthy controls and patients with active (ACD), potential (PCD), or on a gluten-free diet (GFD), to assess changes in the RePrESS gene signature in natural healthy and effector T-IEL populations.